Vault-13

Palo Alto Investors LP

PALO ALTO, CA · CIK 1306923 · 13F filing filed 2022-08-15

SEC-registered investment adviser since 2000 · limited partnership

As an employer

$1.1bn reported value -11.3% vs Q1 2022
33positions
82.8%in top 10
0 new 1 added 10 reduced 2 sold out vs Q1 2022

Holdings, Q2 2022

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 BIOMARIN PHARMACEUTICAL INC COM BMRN BMRN 2,061,373 $170.8m14.89% 14.89% ReducedShares held: Q3 2021 2.2m, Q4 2021 2.2m, Q1 2022 2.1m, Q2 2022 2.1m -78.2k -78,241 -3.7%
2 UNITED THERAPEUTICS CORP DEL COM UTHR UTHR 634,806 $149.6m13.04% 13.04% ReducedShares held: Q3 2021 687.2k, Q4 2021 687.2k, Q1 2022 653.1k, Q2 2022 634.8k -18.3k -18,273 -2.8%
3 ABIOMED INC COM ABMD ABMD 494,397 $122.4m10.67% 10.67% UnchangedShares held: Q3 2021 549.8k, Q4 2021 519.0k, Q1 2022 494.4k, Q2 2022 494.4k
4 INSMED INC COM PAR $.01 INSM INSM 5,840,398 $115.2m10.04% 10.04% ReducedShares held: Q3 2021 6.0m, Q4 2021 6.0m, Q1 2022 5.9m, Q2 2022 5.8m -40.9k -40,901 -0.7%
5 AMICUS THERAPEUTICS INC COM FOLD FOLD 9,847,774 $105.8m9.22% 9.22% ReducedShares held: Q3 2021 10.1m, Q4 2021 10.1m, Q1 2022 9.9m, Q2 2022 9.8m -56.0k -55,987 -0.6%
6 STAAR SURGICAL CO COM PAR $0.01 STAA STAA 1,106,567 $78.5m6.84% 6.84% ReducedShares held: Q3 2021 1.1m, Q4 2021 1.1m, Q1 2022 1.1m, Q2 2022 1.1m -30.4k -30,401 -2.7%
7 BIOGEN INC COM BIIB BIIB 360,981 $73.6m6.42% 6.42% UnchangedShares held: Q3 2021 361.6k, Q4 2021 385.0k, Q1 2022 361.0k, Q2 2022 361.0k
8 REVANCE THERAPEUTICS INC COM RVNC RVNC 4,405,039 $60.9m5.31% 5.31% ReducedShares held: Q3 2021 3.2m, Q4 2021 4.4m, Q1 2022 4.4m, Q2 2022 4.4m -10.7k -10,650 -0.2%
9 PROTHENA CORP PLC SHS PRTA PRTA 1,681,477 $45.7m3.98% 3.98% UnchangedShares held: Q3 2021 1.7m, Q4 2021 1.7m, Q1 2022 1.7m, Q2 2022 1.7m
10 SAGE THERAPEUTICS INC COM SAGE SAGE 851,409 $27.5m2.40% 2.40% ReducedShares held: Q3 2021 617.9k, Q4 2021 781.7k, Q1 2022 851.7k, Q2 2022 851.4k -310 -310 -0.0%
11 VANDA PHARMACEUTICALS INC COM VNDA VNDA 2,491,200 $27.2m2.37% 2.37% UnchangedShares held: Q3 2021 3.8m, Q4 2021 2.8m, Q1 2022 2.5m, Q2 2022 2.5m
12 KARYOPHARM THERAPEUTICS INC COM COM 5,621,533 $25.4m2.21% 2.21% UnchangedShares held: Q3 2021 5.4m, Q4 2021 5.5m, Q1 2022 5.6m, Q2 2022 5.6m
13 ACADIA PHARMACEUTICALS INC COM ACAD ACAD 1,678,196 $23.6m2.06% 2.06% ReducedShares held: Q3 2021 2.3m, Q4 2021 2.3m, Q1 2022 2.3m, Q2 2022 1.7m -573.6k -573,638 -25.5%
14 ALKERMES PLC SHS ALKS ALKS 603,400 $18.0m1.57% 1.57% ReducedShares held: Q3 2021 589.9k, Q4 2021 754.2k, Q1 2022 673.6k, Q2 2022 603.4k -70.2k -70,171 -10.4%
15 EHEALTH INC COM EHTH EHTH 1,654,693 $15.4m1.35% 1.35% AddedShares held: Q3 2021 1.1m, Q4 2021 1.6m, Q1 2022 1.7m, Q2 2022 1.7m +2.4k +2,433 0.1%
16 GOSSAMER BIO INC COM GOSS GOSS 1,750,651 $14.7m1.28% 1.28% ReducedShares held: Q3 2021 1.8m, Q4 2021 1.8m, Q1 2022 1.8m, Q2 2022 1.8m -6.1k -6,106 -0.3%
17 SYNDAX PHARMACEUTICALS INC COM SNDX SNDX 612,600 $11.8m1.03% 1.03% UnchangedShares held: Q3 2021 444.9k, Q4 2021 598.9k, Q1 2022 612.6k, Q2 2022 612.6k
18 ALIGN TECHNOLOGY INC COM ALGN ALGN 44,305 $10.5m0.91% 0.91% UnchangedShares held: Q3 2021 55.4k, Q4 2021 55.4k, Q1 2022 44.3k, Q2 2022 44.3k
19 EPIZYME INC COM EPZM EPZM 6,774,541 $10.0m0.87% 0.87% UnchangedShares held: Q3 2021 6.9m, Q4 2021 5.5m, Q1 2022 6.8m, Q2 2022 6.8m
20 ANAPTYSBIO INC COM ANAB ANAB 431,024 $8.8m0.76% 0.76% UnchangedShares held: Q3 2021 436.6k, Q4 2021 436.6k, Q1 2022 431.0k, Q2 2022 431.0k
21 CLOVIS ONCOLOGY INC COM CLVS CLVS 4,473,967 $8.1m0.70% 0.70% UnchangedShares held: Q3 2021 4.5m, Q4 2021 4.0m, Q1 2022 4.5m, Q2 2022 4.5m
22 GRITSTONE BIO INC COM GRTS GRTS 2,330,504 $5.6m0.49% 0.49% UnchangedShares held: Q3 2021 2.4m, Q4 2021 2.4m, Q1 2022 2.3m, Q2 2022 2.3m
23 KEZAR LIFE SCIENCES INC COM COM 656,200 $5.4m0.47% 0.47% UnchangedShares held: Q3 2021 656.2k, Q4 2021 656.2k, Q1 2022 656.2k, Q2 2022 656.2k
24 CYTOKINETICS INC COM NEW CYTK CYTK 111,717 $4.4m0.38% 0.38% UnchangedShares held: Q3 2021 123.7k, Q4 2021 123.7k, Q1 2022 111.7k, Q2 2022 111.7k
25 TRAVERE THERAPEUTICS INC COM TVTX TVTX 166,069 $4.0m0.35% 0.35% UnchangedShares held: Q3 2021 166.1k, Q4 2021 166.1k, Q1 2022 166.1k, Q2 2022 166.1k
26 MIRUM PHARMACEUTICALS INC COM MIRM MIRM 64,700 $1.3m0.11% 0.11% UnchangedShares held: Q3 2021 0, Q4 2021 64.7k, Q1 2022 64.7k, Q2 2022 64.7k
27 ALIMERA SCIENCES INC COM NEW ALIM ALIM 200,919 $1.1m0.10% 0.10% UnchangedShares held: Q3 2021 200.9k, Q4 2021 200.9k, Q1 2022 200.9k, Q2 2022 200.9k
28 NOVAVAX INC COM NEW NVAX NVAX 12,500 $643.0k0.06% 0.06% UnchangedShares held: Q3 2021 0, Q4 2021 12.5k, Q1 2022 12.5k, Q2 2022 12.5k
29 ALDEYRA THERAPEUTICS INC COM ALDX ALDX 160,800 $642.0k0.06% 0.06% UnchangedShares held: Q3 2021 160.8k, Q4 2021 160.8k, Q1 2022 160.8k, Q2 2022 160.8k
30 MAGENTA THERAPEUTICS INC COM COM 432,300 $519.0k0.05% 0.05% UnchangedShares held: Q3 2021 432.3k, Q4 2021 432.3k, Q1 2022 432.3k, Q2 2022 432.3k
31 UROGEN PHARMA LTD COM URGN URGN 24,500 $201.0k0.02% 0.02% UnchangedShares held: Q3 2021 24.5k, Q4 2021 24.5k, Q1 2022 24.5k, Q2 2022 24.5k
32 TACTILE SYS TECHNOLOGY INC COM TCMD TCMD 27,100 $198.0k0.02% 0.02% UnchangedShares held: Q3 2021 27.1k, Q4 2021 27.1k, Q1 2022 27.1k, Q2 2022 27.1k
33 MARINUS PHARMACEUTICALS INC COM NEW MRNS MRNS 31,330 $152.0k0.01% 0.01% UnchangedShares held: Q3 2021 31.3k, Q4 2021 31.3k, Q1 2022 31.3k, Q2 2022 31.3k

Sold out since Q1 2022

SecurityTickerShares held beforeValue then
RIGEL PHARMACEUTICALS INC 652,395 $2.0m652.4k shares
KALEIDO BIOSCIENCES INC KLDO KLDO 309,692 $511.0k309.7k shares